Cited2 is required for the proper formation of the hyaloid vasculature and for lens morphogenesis

Development

Volumn 135, Issue 17, 2008, Pages 2939-2948

  Chen, Yu ^a   Doughman, Yong Qiu ^b   Gu, Shi ^a   Jarrell, Andrew ^a   Aota, Shin Ichi ^c   Cvekl, Ales ^d   Watanabe, Michiko ^b   Dunwoodie, Sally L ^e   Johnson, Randall S ^f   van Heyningen, Veronica ^g   Kleinjan, Dirk A ^g   Beebe, David C ^h   Yang, Yu Chung ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g WESTERN GENERAL HOSPITAL   (United Kingdom)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cited2; Hyaloid vasculature; Lens development; Mouse

Indexed keywords

CARRIER PROTEIN; PROTEIN CITED2; PROTEIN HIF1A; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; EMBRYO; EYE DEVELOPMENT; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; HYALOID VASCULATURE; LENS; MORPHOGENESIS; MOUSE; NONHUMAN; PETERS ANOMALY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; CELL DEATH; CELL PROLIFERATION; CORNEA; EYE PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTEGRASES; LENS, CRYSTALLINE; MICE; MORPHOGENESIS; PAIRED BOX TRANSCRIPTION FACTORS; PHENOTYPE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; VITREOUS BODY;

EID: 53349120212     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.021097     Document Type: Article

References (66)

1. Aota, S., Nakajima, N., Sakamoto, R., Watanabe, S., Ibaraki, N. and Okazaki, K. (2003). Pax6 autoregulation mediated by direct interaction of Pax6 protein with the head surface ectoderm-specific enhancer of the mouse Pax6 gene. Dev. Biol. 257, 1-13.
2. Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F. and Livingston, D. M. (1996). An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93, 12969-12973.
3. Ash, J. D. and Overbeek, P. A. (2000). Lens-specific VEGF-A expression induces angioblast migration and proliferation and stimulates angiogenic remodeling. Dev. Biol. 223, 383-398.
4. Ashery-Padan, R., Marquardt, T., Zhou, X. and Gruss, P. (2000). Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev. 14, 2701-2711.
5. Bamforth, S. D., Braganca, J., Eloranta, J. J., Murdoch, J. N., Marques, F. I., Kranc, K. R., Farza, H., Henderson, D. J., Hurst, H. C. and Bhattacharya, S. (2001). Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat. Genet. 29, 469-474.
6. Bamforth, S. D., Braganca, J., Farthing, C. R., Schneider, J. E., Broadbent C., Michell, A. C., Clarke, K., Neubauer, S., Norris, D., Brown, N. A. et al. (2004). Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat. Genet. 36, 1189-1196.
7. Barbera, J. P., Rodriguez, T. A., Greene, N. D., Weninger, W. J., Simeone, A., Copp, A. J., Beddington, R. S. and Dunwoodie, S. (2002). Folic acid prevents exencephaly in Cited2 deficient mice. Hum. Mol. Genet. 11, 283-293.
8. Bassnett, S. and McNulty, R. (2003). The effect of elevated intraocular oxygen on organelle degradation in the embryonic chicken lens. J. Exp. Biol. 206, 4353-4361.
9. Beebe, D., Garcia, C., Wang, X., Rajagopal, R., Feldmeier, M., Kim, J. Y., Chytil, A., Moses, H., Ashery-Padan, R. and Rauchman, M. (2004). Contributions by members of the TGFbeta superfamily to lens development. Int. J. Dev. Biol. 48, 845-856.
10. Beebe, D. C. (2008). Maintaining transparency: A review of the developmental physiology and pathophysiology of two avascular tissues. Semin. Cell Dev Biol. 19, 125-133.
11. Bhattacharya, S., Michels, C. L., Leung, M. K., Arany, Z. P., Kung, A. L. and Livingston, D. M. (1999). Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13, 64-75.
12. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P. et al. (1998). Role of HIF-1[alpha] in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490.
13. Chen, Y., Haviernik, P., Bunting, K. D. and Yang, Y. C. (2007). Cited2 is required for normal hematopoiesis in the murine fetal liver. Blood 110, 2889-2898.
14. Chou, Y. T., Wang, H., Chen, Y., Danielpour, D. and Yang, Y. C. (2006). Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene 25, 5547-5560.
15. Chow, R. L. and Lang, R. A. (2001). Early eye development in vertebrates. Annu. Rev. Cell Dev. Biol. 17, 255-296.
16. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V. et al. (2003). HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
17. Davis-Silberman, N., Kalich, T., Oron-Karni, V., Marquardt, T., Kroeber, M., Tamm, E. R. and Ashery-Padan, R. (2005). Genetic dissection of Pax6 dosage requirements in the developing mouse eye. Hum. Mol. Genet. 14, 2265-2276.
18. Dimanlig, P. V., Faber, S. C., Auerbach, W., Makarenkova, H. P. and Lang, R. A. (2001). The upstream ectoderm enhancer in Pax6 has an important role in lens induction. Development 128, 4415-4424.
19. Donner, A. L., Episkopou, V. and Maas, R. L. (2007). Sox2 and Pou2f1 interact to control lens and olfactory placode development. Dev. Biol. 303, 784-799.
20. Dunwoodie, S. L., Rodriguez, T. A. and Beddington, R. S. P. (1998). Msg1 and Mrgl, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis. Mech. Dev. 72, 27-40.
21. Flamme, I., Breier, G. and Risau, W. (1995). Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev. Biol. 169, 699-712.
22. Freedman, S. J., Sun, Z. Y., Kung, A. L., France, D. S., Wagner, G. and Eck, M. J. (2003). Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat. Struct. Biol. 10, 504-512.
23. Glenn, D. J. and Maurer, R. A. (1999). MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. J. Biol. Chem. 274, 36159-36167.
24. Goldberg, M. F. (1997). Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 124, 587-626.
25. Grindley, J. C., Davidson, D. R. and Hill, R. E. (1995). The role of Pax-6 in eye and nasal development. Development 121, 1433-1442.
26. Haddad, R., Font, R. L. and Reeser, F. (1978). Persistent hyperplastic primary vitreous. A clinicopathologic study of 62 cases and review of the literature. Surv. Ophthalmol. 23, 123-134.
27. Hanson, I. M., Fletcher, J. M., Jordan, T., Brown, A., Taylor, D., Adams, R. J., Punnett, H. H. and van Heyningen, V. (1994). Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat. Genet. 6, 168-173.
28. Hill, R. E., Favor, J., Hogan, B. L. M., Ton, C. C. T., Saunders, G. F., Hanson, I. M., Prosser, J., Jordan, T., Hastie, N. D. and van Heyningen, V. (1991). Mouse Small eye results from mutations in a paired-like homeobox-containing gene. Nature 354, 522-525.
29. Ito, M. and Yoshioka, M. (1999). Regression of the hyaloid vessels and pupillary membrane of the mouse. Anat. Embryol. 200, 403-411.
30. Kammandel, B., Chowdhury, K., Stoykova, A., Aparicio, S., Brenner, S. and Gruss, P. (1999). Distinct cis-essential modules direct the time-space pattern of the Pax6 gene activity. Dev. Biol. 205, 79-97.
31. Kaufman, M. H., Chang, H. H. and Shaw, J. P. (1995). Craniofacial abnormalities in homozygous Small eye (Sey/Sey) embryos and newborn mice. J. Anat. 186, 607-617.
32. Kenyon, K. R. (1975). Mesenchymal dysgenesis in Peter's anomaly, sclerocornea and congenital endothelial dystrophy. Exp. Eye Res. 21, 125-142.
33. Kleinjan, D. A., Seawright, A., Schedl, A., Quinlan, R. A., Danes, S. and van Heyningen, V. (2001). Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6. Hum. Mol. Genet. 10, 2049-2059.
34. Kleinjan, D. A., Seawright, A., Elgar. G. and van Heyningen, V. (2002). Characterization of a novel gene adjacent to PAX6, revealing synteny conservation with functional significance. Mamm. Genome 13, 102-107.
35. Kleinjan, D. A., Seawright, A., Mella, S., Carr, C. B., Tyas, D. A., Simpson, T. I., Mason, J. O., Price, D. J. and van Heyningen, V. (2006). Long-range downstream enhancers are essential for Pax6 expression. Dev Biol. 299, 563-581.
36. Leung, M. K., Jones, T., Michels, C. L., Livingston, D. M. and Bhattacharya, S. (1999). Molecular cloning and chromosomal localization of the human CITED2 gene encoding p35srj/Mrg1. Genomics 61, 307-313.
37. Liu, Y., Cox, S. R., Morita, T. and Kourembanas, S. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circ. Res. 77, 638-643.
38. Mitchell, C. A., Rutland, C. S., Walker, M., Nasir, M., Foss, A. J., Stewart, C., Gerhardt, H., Konerding, M. A., Risau, W. and Drexler, H. C. (2006). Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens. Angiogenesis 9, 209-224.
39. Myles, W. M., Flanders, M. E., Chitayat, D. and Brownstein, S. (1992). Peters' anomaly: a clinicopathologic study. J. Pediatr Ophthalmol. Strabismus. 29, 374-381.
40. Pollard, Z. F. (1997). Persistent hyperplastic primary vitreous: diagnosis, treatment and results. Trans. Am. Ophthalmol. Soc. 95, 487-549.
41. Preis, J. I., Wise, N., Solloway, M. J., Harvey, R. P., Sparrow, D. B. and Dunwoodie, S. L. (2006). Generation of conditional Cited2 null alleles. Genesis 44, 579-583.
42. Pugh, C. W. and Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684.
43. Qu, X., Lam, E., Doughman, Y. Q., Chen, Y., Chou, Y. T., Lam, M., Turakhia, M., Dunwoodie, S. L., Watanabe, M., Xu, B. et al. (2007). Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J. 26, 4445-4456.
44. Quiring, R., Walldorf, U., Kloter, U. and Gehring, W. J. (1994). Homology of the eyeless gene of Drosophila to the Small eye gene in mice and Aniridia in humans. Science 265, 785-789.
45. Rutland, C. S., Mitchell, C. A., Nasir, M., Konerding, M. A. and Drexler H. C. (2007). Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter. Mol. Vis. 13, 47-56.
46. Schedl, A., Ross, A., Lee, M., Engelkamp, D., Rashbass, P., van Heyningen. V. and Hastie, N. D. (1996). Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell 86, 71-82.
47. Shioda, T., Fenner, M. H. and Isselbacher, K. J. (1997). MSG1 and its related protein MRG1 share a transcription activating domain. Gene 204, 235-241.
48. Shui, Y. B., Wang, X., Hu, J. S., Wang, S. P., Garcia, C. M., Potts, J. D., Sharma, Y. and Beebe, D. C. (2003). Vascular endothelial growth factor expression and signaling in the lens. Invest. Ophthalmol. Vis. Sci. 44, 3911-3919.
49. Shui, Y. B., Fu, J. J., Garcia, C., Dattilo, L. K., Rajagopal, R., McMillan, S., Mak, G., Holekamp, N. M., Lewis, A. and Beebe, D. C. (2006). Oxygen Distribution in the Rabbit Eye and Oxygen Consumption by the Lens. Invest Ophthalmol. Vis. Sci. 47, 1571-1580.
50. Shweiki, D., Itin, A., Soffer, D. and Keshet E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
51. Smith, G. M. and Velzeboer, C. M. (1975). Peter's anomaly. Ophthalmologica 171, 318-320.
52. Sun, H. B., Zhu, Y. X., Yin, T., Sledge, G. and Yang, Y. C. (1998). MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. Proc, Natl. Acad. Sci. USA 95, 13555-13560.
53. Tien, E. S., Davis, J. W. and Vanden Heuvel, J. P. (2004). Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator. J. Biol. Chem. 279, 24053-24063.
54. Val, P., Martinez-Barbera, J. P. and Swain, A. (2007). Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 134, 2349-2358.
55. van Raamsdonk, C. D. and Tilghman, S. M. (2000). Dosage requirement and allelic expression of PAX6 during lens placode formation. Development 127,, 5439-5448.
56. Walther, C. and Gruss, P. (1991). Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 113, 1435-1449.
57. Weninger, W. J., Floro, K. L., Bennett, M. B., Withington, S. L., Preis, J. I., Barbera, J. P., Mohun, T. J. and Dunwoodie, S. L. (2005). Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development 132, 1337-1348.
58. West-Mays, J. A., Zhang, J., Nottoli, T., Hagopian-Donaldson, S., Libby, D., Strissel, K. J. and Williams, T. (1999). AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle. Dev. Biol. 206, 46-62.
59. Williams, S. C., Altmann, C. R., Chow, R. L., Hemmati-Brivanlou, A. and Lang, R. A. (1998). A highly conserved lens transcriptional control element from the Pax-6 gene. Mech. Dev. 73, 225-229.
60. Withington, S. L., Scott, A. N., Saunders, D. N., Lopes, F. K., Preis, J. I., Michalicek, J., Maclean, K., Sparrow, D. B., Barbera, J. P. and Dunwoodle, S. L. (2006). Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta. Dev. Biol. 294, 67-82.
61. Xu, B., Doughman, Y., Turakhia, M., Jiang, W., Landsettle, C. E., Agani, F. H., Semenza, G. L., Watanabe, M. and Yang, Y. C. (2007). Partial rescue of defects in Cited2-deficient embryos by Hir-1 alpha heterozygosity. Dev. Biol. 301, 130-140.
62. Xu, P. X., Zhang, X., Heaney, S., Yoon, A., Michelson, A. M. and Maas, R. L. (1999). Regulation of Pax6 expression is conserved between mice and flies. Development 126, 383-395.
63. Yang, Y. and Cvekl, A. (2005). Tissue-specific regulation of the mouse alphaA-crystallin gene in lens via recruitment of Pax6 and c-Maf to its promoter. J. Mol. Biol. 19, 453-469.
64. Yang, Y., Stopka, T., Golestaneh, N., Wang, Y., Wu, K., Li, A., Chauhan, B. K., Gao, C. Y., Cveklova, K., Duncan, M. K. et al. (2006). Regulation of alphaA-crystallin via Pax6, c-Maf, CREB and a broad domain of lens-specific chromatin. EMBO J. 25, 2107-2118.
65. Yin, Z., Haynie, J., Yang, X., Han, B., Kiatchoosakun, S., Restivo, J., Yuan, S., Prabhakar, N. R., Herrup, K., Conlon, R, A. et al. (2002). The essential role of Cited2, a negative regulator for HIF-1 alpha, in heart development and neurulation. Proc Natl. Acad. Sci. USA 99, 10488-10493.
66. Yoon, G. (2001). Neonatal corneal opacity: a case study of Peters' anomaly. Neonatal Netw. 20, 65-72.